Beyond animal testing: The rise of organoids in toxicology research
Drug Discovery World
MARCH 20, 2024
Unlike pluripotent stem cell-derived organoids, PDOs do not require additional reprogramming to develop in fully functional mini-organs, hence, preserving the genetic and epigenetic makeup of the patient tissue through passages, including crucial metabolic transporters, and proteins present in the patient’s original tissue.
Let's personalize your content